Results 171 to 180 of about 1,704,518 (313)
Choroid Plexus Enlargement and USPIO‐Based Inflammatory Feature in Cerebral Small Vessel Disease
ABSTRACT Objective The choroid plexus (CP) is a key component of the blood–cerebrospinal fluid barrier (BCSFB), but its mechanism of action in cerebral small vessel disease (CSVD) remains unclear. This study investigated CP volume (CPV) alterations and their association with conventional imaging markers in CSVD and explored the underlying role of ...
Yongqiang Qu +11 more
wiley +1 more source
[Côtes de la Basse Normandie et Côtes de la Haute Normandie] / Lith. de Delevoye-Barrier
Échelle(s) : [Échelle non déterminable]Appartient à l’ensemble documentaire : BNormand1Appartient à l’ensemble documentaire ...
Delevoye-Barrier (Dieppe). Lithographie. Lithographe
core
Short-Chain Fatty Acids: A Key Modulator of Sepsis-Associated Acute Respiratory Distress Syndrome. [PDF]
Sun Y, He M, Li J, Wu C, Pan S.
europepmc +1 more source
ABSTRACT Background Cognitive impairment is a common non‐motor symptom in Multiple Sclerosis (MS), negatively affecting autonomy and Quality of Life (QoL). Innovative rehabilitation strategies, such as semi‐immersive virtual reality (VR) and computerized cognitive training (CCT), may offer advantages over traditional cognitive rehabilitation (TCR ...
Maria Grazia Maggio +8 more
wiley +1 more source
Editorial: Host-microbiota interactions in IBD: immune modulation and barrier function. [PDF]
Li H +3 more
europepmc +1 more source
ABSTRACT Background and Purpose White matter hyperintensities (WMH) are a core neuroimaging marker of cerebral small vessel disease (CSVD). Sleep apnoea (SA) is a recognized vascular risk factor, but its associations with regional WMH burden, short‐interval WMH change and cognitive performance in population‐based cohorts remain incompletely defined. We
Peng Cheng +4 more
wiley +1 more source
Native and Non-Native Populations Respond Unevenly to River Barrier Removals. [PDF]
Dolan EJ +7 more
europepmc +1 more source
Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS
ABSTRACT Objective Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels are believed to reflect mainly acute and chronic disease processes in multiple sclerosis (MS), respectively. In this study, we investigated whether dimethyl fumarate (DMF) and rituximab (RTX) differentially affect these biomarkers.
F. Shawket +14 more
wiley +1 more source
Plan du port de Dieppe en 1600 ; Plan d'Étretat / Lith. de Delevoye-Barrier
Échelle(s) : [Échelles diverses]Appartient à l’ensemble documentaire ...
Delevoye-Barrier (Dieppe). Lithographie. Lithographe
core

